Stock Traders Purchase Large Volume of ARK Genomic Revolution ETF Put Options (BATS:ARKG)

ARK Genomic Revolution ETF (BATS:ARKG) was the recipient of unusually large options trading on Thursday. Investors purchased 14,158 put options on the stock. This is an increase of approximately 60% compared to the typical volume of 8,868 put options.

ARK Genomic Revolution ETF Price Performance

Shares of BATS:ARKG opened at $23.32 on Friday. The stock has a 50-day moving average price of $28.81 and a 200 day moving average price of $28.43.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in ARKG. Operose Advisors LLC bought a new position in ARK Genomic Revolution ETF during the 3rd quarter valued at approximately $25,000. Stephens Consulting LLC bought a new position in ARK Genomic Revolution ETF during the 3rd quarter valued at approximately $28,000. LM Advisors LLC bought a new position in ARK Genomic Revolution ETF during the 4th quarter valued at approximately $28,000. Principal Securities Inc. bought a new position in ARK Genomic Revolution ETF during the 4th quarter valued at approximately $32,000. Finally, Allworth Financial LP increased its position in ARK Genomic Revolution ETF by 65.3% during the 3rd quarter. Allworth Financial LP now owns 1,425 shares of the company’s stock valued at $40,000 after buying an additional 563 shares in the last quarter.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.